Aquestive Therapeutics, Inc. — Director's Dealing 2018

Jul 25, 2018

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Aquestive Therapeutics, Inc. (AQST)
CIK: 0001398733
Period of Report: 2018-07-24

Reporting Person: BRATTON DOUGLAS K (N/A)
Reporting Person: MRX Partners, LLC (N/A)
Reporting Person: MonoLine RX, L.P. (N/A)
Reporting Person: MonoLine RX II, L.P. (N/A)
Reporting Person: Monoline RX III, L.P. (N/A)
Reporting Person: MonoSol Rx Genpar, L.P. (N/A)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	75085	Direct
Common Stock	2249077	Indirect
Common Stock	2213314	Indirect
Common Stock	4032907	Indirect
Common Stock	2755541	Indirect
Common Stock	87455	Indirect

Footnotes

F1: Represents shares of the Issuer's non-voting common stock. The non-voting shares will become regular voting common stock upon the consummation of the Issuer's initial public
offering.

F2: These securities are owned, as indicated, by MRX Partners, LLC ("MRX Partners"), MonoLine Rx, L.P. ("Monoline"), MonoLine Rx II, L.P. ("Monoline II"), MonoLine Rx III, L.P. ("Monoline III") and Monosol Rx Genpar, L.P. ("Monosol Rx Genpar," and collectively with MRX Partners, Monoline, Monoline II and Monoline III, the "Monosol Entities"). Bratton Capital Management L.P. ("Bratton Capital Management") is the general partner of each of the Monosol Entities (other than Monoline Rx Genpar); Bratton Capital Inc. ("Bratton") is the general partner of Bratton Capital Management and Monosol Rx Genpar; and the Reporting Person, Douglas K. Bratton, is the sole director of Bratton.

F3: The Monosol Entities are each ultimately controlled by Mr. Bratton; Mr. Bratton has voting and investment power over all shares held by the Monosol Entities; and Bratton Capital Management, Bratton, and Mr. Bratton may each be deemed to beneficially own all shares held of record by the Monosol Entities. Each such entity and Mr. Bratton disclaims beneficial ownership of the reported securities except to the extent of its or his respective pecuniary interest therein.

F4: These securities are owned of record by MRX Partners.

F5: These securities are owned of record by Monoline.

F6: These securities are owned of record by Monoline II.

F7: These securities are owned of record by Monoline III.

F8: These securities are owned of record by Monosol Rx Genpar.